National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Childhood Central Nervous System Embryonal Tumors Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 08/13/2009



Purpose of This PDQ Summary






General Information






Cellular Classification of Central Nervous System Embryonal Tumors






Staging of Medulloblastoma






Treatment Option Overview






Treatment for Newly Diagnosed Childhood Medulloblastoma







Staging of Pineoblastoma






Treatment Options for Newly Diagnosed Pineoblastoma and Pineal Parenchymal Tumors of Intermediate Differentiation






Staging of Supratentorial Primitive Neuroectodermal Tumors






Treatment Options for Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors






Medulloepithelioma and Ependymoblastoma






Recurrent Childhood Central Nervous System Embryonal Tumors






Get More Information From NCI






Changes to This Summary (08/13/2009)






More Information



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Office of Biorepositories and Biospecimen Research

The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates
Staging of Pineoblastoma

Staging for children with pineoblastomas is the same as that performed for children with medulloblastoma.[1] Dissemination at the time of diagnosis occurs in 10% to 30% of patients.[1] Because of the location of the tumor, total resections are uncommon, and most patients have only a biopsy or a subtotal resection before postsurgical treatment.[1,2] Prognosis is worse for patients with disseminated disease at the time of diagnosis.[1]

References

  1. Jakacki RI, Zeltzer PM, Boyett JM, et al.: Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Childrens Cancer Group. J Clin Oncol 13 (6): 1377-83, 1995.  [PUBMED Abstract]

  2. Timmermann B, Kortmann RD, Kühl J, et al.: Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91. J Clin Oncol 20 (3): 842-9, 2002.  [PUBMED Abstract]

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov